Cargando…
High-flow nasal cannula for COVID-19 patients: risk of bio-aerosol dispersion
HFNC seems to increase droplet spread, so caution should be taken if it is applied for COVID-19, and adequate protective measures should be provided. Further research on viral spread and risks associated with HFNC therapy in COVID-19 patients is needed. https://bit.ly/3gQjjrY
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453729/ https://www.ncbi.nlm.nih.gov/pubmed/32859674 http://dx.doi.org/10.1183/13993003.03004-2020 |